158 related articles for article (PubMed ID: 38058404)
61. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
62. Safety and efficacy of hypofractionated stereotactic body reirradiation in head and neck cancer: Long-term follow-up of a large series.
Kress MA; Sen N; Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Hwang J; Harter KW
Head Neck; 2015 Oct; 37(10):1403-9. PubMed ID: 24824359
[TBL] [Abstract][Full Text] [Related]
63. Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Orlandi E; Tomatis S; Potepan P; Bossi P; Mongioj V; Carrara M; Palazzi M; Franceschini M; Bergamini C; Locati L; Iannacone E; Guzzo M; Ibba T; Crippa F; Licitra L; Pignoli E; Fallai C
Future Oncol; 2013 Jan; 9(1):103-14. PubMed ID: 23252567
[TBL] [Abstract][Full Text] [Related]
64. High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma - A DAHANCA 19 study.
Kristensen MH; Holm AIS; Hansen CR; Zukauskaite R; Samsøe E; Maare C; Johansen J; Primdahl H; Bratland Å; Kristensen CA; Andersen M; Overgaard J; Eriksen JG
Clin Transl Radiat Oncol; 2024 May; 46():100772. PubMed ID: 38596816
[TBL] [Abstract][Full Text] [Related]
65. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
[TBL] [Abstract][Full Text] [Related]
66. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
[TBL] [Abstract][Full Text] [Related]
67. Analysis of loco-regional failures in head and neck cancer after radical radiation therapy.
De Felice F; Thomas C; Barrington S; Pathmanathan A; Lei M; Urbano TG
Oral Oncol; 2015 Nov; 51(11):1051-1055. PubMed ID: 26506048
[TBL] [Abstract][Full Text] [Related]
68. Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume.
Nissi L; Suilamo S; Kytö E; Vaittinen S; Irjala H; Minn H
Clin Transl Radiat Oncol; 2021 Mar; 27():139-146. PubMed ID: 33665383
[TBL] [Abstract][Full Text] [Related]
69. Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer.
Chen SA; Schuster DM; Mister D; Liu T; Godette K; Torres MA
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):309-14. PubMed ID: 23312271
[TBL] [Abstract][Full Text] [Related]
70. Intensity modulated radiation therapy with pulsed reduced dose rate as a reirradiation strategy for recurrent central nervous system tumors: An institutional series and literature review.
Murphy ES; Rogacki K; Godley A; Qi P; Reddy CA; Ahluwalia MS; Peereboom DM; Stevens GH; Yu JS; Kotecha R; Suh JH; Chao ST
Pract Radiat Oncol; 2017; 7(6):e391-e399. PubMed ID: 28666902
[TBL] [Abstract][Full Text] [Related]
71. Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence.
Kim YS
Radiat Oncol J; 2017 Mar; 35(1):1-15. PubMed ID: 28395502
[TBL] [Abstract][Full Text] [Related]
72. Outcomes after reirradiation for recurrent nasopharyngeal carcinoma: North American experience.
Karam I; Huang SH; McNiven A; Su J; Xu W; Waldron J; Bayley AJ; Kim J; Cho J; Ringash J; Hope A; Chen E; Chan B; Goldstein D; O'Sullivan B; Giuliani ME
Head Neck; 2016 Apr; 38 Suppl 1():E1102-9. PubMed ID: 26451876
[TBL] [Abstract][Full Text] [Related]
73. Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.
Rubino F; Schur S; McGovern SL; Kamiya-Matsuoka C; DeMonte F; Raza SM
J Neurosurg; 2023 Sep; 139(3):798-809. PubMed ID: 36738459
[TBL] [Abstract][Full Text] [Related]
74. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY
JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229
[TBL] [Abstract][Full Text] [Related]
75. Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study.
Zenga J; Graboyes E; Janz T; Drake V; Rettig E; Desai S; Nickel C; Shabani S; Padhya T; Scarpinato M; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Wong S; Jackson RS; Pipkorn P
Otolaryngol Head Neck Surg; 2019 Jul; 161(1):74-81. PubMed ID: 30753110
[TBL] [Abstract][Full Text] [Related]
76. Prognostic factors and selection criteria in the retreatment of head and neck cancers.
May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE
Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802
[TBL] [Abstract][Full Text] [Related]
77. Proton therapy for reirradiation of progressive or recurrent chordoma.
McDonald MW; Linton OR; Shah MV
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
[TBL] [Abstract][Full Text] [Related]
78. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
[TBL] [Abstract][Full Text] [Related]
79. Recurrence patterns of pancreatic cancer treated with adjuvant intensity modulated radiotherapy.
Yıldırım HC; Şahin M; Ergen ŞA; Karaçam SÇ; Öksüz DÇ
Rep Pract Oncol Radiother; 2022; 27(3):440-448. PubMed ID: 36186698
[TBL] [Abstract][Full Text] [Related]
80. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer.
Schoenfeld GO; Amdur RJ; Morris CG; Li JG; Hinerman RW; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):377-85. PubMed ID: 18164838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]